A slight tremor in one hand. A subtle stiffness while getting out of a chair. A handwriting that has gradually become smaller over the past few months. These are the kinds of changes that are easy to ignore until they become prominent.
Parkinson’s disease is a progressive neurological disorder that affects movement, balance and coordination. It ranks as the second most common neurodegenerative condition after Alzheimer’s disease, with the World Health Organisation estimating that over 8.5 million people live with it globally. In India, the prevalence is rising steadily as the population ages, with growing caseloads reported across major urban centres, including Delhi, Mumbai, Ahmedabad, Kolkata, Bengaluru and other cities.
For anyone asking what Parkinson’s disease is, this guide covers the essential facts: what it means clinically, what causes it, what the early symptoms of Parkinson’s disease are, how it is classified and staged and then what treatment options are available as of today. The aim is not to replace a neurologist’s assessment but to provide clear, medically grounded information that helps patients and families make informed decisions.
Parkinson’s Disease: What Does It Mean?
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily disrupts the motor system. It occurs when neurons in a region of the brain called the substantia nigra become damaged or die. These neurons are responsible for producing dopamine, a neurotransmitter that plays a central role in coordinating smooth, purposeful movement.
As dopamine levels decline, the brain loses its ability to regulate movement effectively. This leads to the most common motor symptoms: tremor, rigidity, slowness of movement and postural instability. However, Parkinson’s disease is not purely a movement disorder. It also affects other neurotransmitter systems, which explains why patients frequently experience non-motor symptoms such as the following:
- Sleep disturbances and fatigue
- Mood changes, including depression and anxiety disorders
- Cognitive shifts, particularly in attention and executive function
- Autonomic dysfunction, such as constipation, blood pressure fluctuations, and urinary issues
- Loss of sense of smell (anosmia), which may appear years before motor symptoms happen
From a diagnostic standpoint, Parkinson’s disease is classified as a neurodegenerative disorder. Standardised neurological examinations and clinical assessment scales remain the primary tools for tracking disease progression and tailoring management plans.
Parkinson’s Disease Stages: How Does the Condition Progress?
Medical professionals commonly use the Hoehn and Yahr scale to classify the progression of Parkinson’s disease into five structural stages. This staging system helps clinicians assess severity and plan appropriate care.
- Stage 1: Mild symptoms affecting only one side of the body. Tremor or movement changes may be present but do not interfere with daily activities. Most individuals at this stage continue functioning independently without noticeable limitations.
- Stage 2: Symptoms become bilateral, affecting both sides of the body. Tremor, rigidity and slowness of movement as these become apparent. Walking and posture may be affected, but independence is generally maintained.
- Stage 3: Considered mid-stage. Loss of balance becomes a defining feature, and falls become more frequent. Movements are noticeably slower. Daily activities are significantly impaired, though the individual can still live independently with modifications.
- Stage 4: Symptoms are severe and limiting. Standing without assistance may still be possible, but walking typically requires a walker or other support device. The individual needs substantial help with daily living activities.
- Stage 5: The most advanced stage. Stiffness in the legs may make standing and walking impossible. The individual is wheelchair-dependent or bedridden and requires full-time nursing care.
It is important to note that progression varies considerably from person to person. Some individuals remain at Stage 1 or 2 for many years, while others progress more rapidly. The rate of progression cannot be reliably predicted at the time of diagnosis and treatment.
Parkinson’s Disease Causes and Risk Factors?
The exact Parkinson’s disease causes remain incompletely understood. Current evidence points to a complex interaction between genetic susceptibility and environmental exposure rather than any single identifiable trigger.
Genetic Factors
- While most cases of Parkinson’s disease are not directly inherited, specific genetic mutations can increase an individual’s risk.
- Mutations in genes such as LRRK2, PARK7, PINK1 and SNCA have been identified in a few familial cases.
- Having a first-degree relative with Parkinson’s modestly increases risk, though it does not determine outcome.
- Genetic testing can help identify hereditary risk factors, particularly in families with multiple affected members.
For families with a history of Parkinson’s or early-onset cases, Whole Exome Sequencing (WES) offered at Unipath Specialty Laboratory analyses all protein-coding regions of the genome to identify mutations in genes such as LRRK2, PINK1, PARK7 and SNCA that are associated with hereditary Parkinson’s risk. This test provides actionable genetic clarity that can inform both clinical management and family screening decisions.
Environmental Factors
- Prolonged exposure to herbicides, pesticides and certain industrial chemicals has been associated with a marginally higher risk than others
- Rural residence and well-water consumption have been linked to increased incidence in some epidemiological studies.
- Occupational exposure to heavy metals, particularly manganese, may contribute to Parkinson ’s-like symptoms.
Age and Gender
- Age is the single most significant identifiable risk factor. The condition typically manifests after age 60, with incidence rising sharply with advancing age.
- Men are approximately 1.5 times more likely to develop Parkinson’s disease than women, though the reasons for this disparity remain under investigation.
- Early-onset Parkinson’s (before age 50) accounts for roughly 5–10% of all cases and tends to have a stronger genetic component.
Parkinson’s Disease Symptoms and Signs to Watch?
Parkinson’s disease symptoms develop gradually, often beginning so subtly that they are dismissed as the normal ageing process. Recognising the early symptoms of Parkinson’s disease is critical because early intervention can meaningfully improve quality of life and slow functional decline.
Motor Symptoms
- Resting tremor (Parkinson tremor): A rhythmic shaking that typically begins in one hand or fingers while at rest. The classic “pill-rolling” tremor and a back-and-forth rubbing of the thumb and forefinger is frequently one of the most recognisable signs of Parkinson’s.
- Bradykinesia: Progressive slowness of movement that makes everyday tasks increasingly cumbersome and time-consuming. Movements that were once automatic, such as buttoning a shirt or rising from a chair, require conscious and extra effort.
- Muscle rigidity: Stiffness that can occur in any part of the body, limiting range of motion and frequently causing pain. Rigidity may be continuous or may present as a “cogwheel” resistance during passive movement.
- Postural instability: Impaired balance and a tendency to fall, particularly during turns or when changing direction. Posture may become increasingly stooped with time.
- Loss of automatic movements: Reduced ability to perform unconscious actions such as blinking, facial expression, arm swing while walking and swallowing.
- Speech changes: Speech may become soft, rapid, monotone, or slurred. Hesitation before speaking is common.
- Writing changes (micrographia): Handwriting progressively becomes smaller, messy and cramped and often one of the earliest noticeable changes.
Non-Motor Symptoms
- Depression, anxiety and apathy, which may precede motor symptoms by several years
- Sleep disorders, including REM sleep behaviour disorder and insomnia
- Constipation and other gastrointestinal issues
- Reduced sense of smell that grows with time
- Cognitive changes, ranging from mild difficulties with attention to, in later stages, dementia
The clinical significance of non-motor symptoms cannot be overstated. In many cases, they affect quality of life more profoundly than the motor symptoms themselves and they frequently appear years before a Parkinson's tremor or visible movement change prompts medical evaluation.
Types of Parkinsonism?
While idiopathic Parkinson’s disease (where no specific cause is identified) accounts for most cases, several related conditions fall under the broader category of Parkinson syndrome:
- Idiopathic Parkinson’s Disease: The most common form, characterised by progressive dopamine depletion in the substantia nigra. This generally responds well to dopaminergic medication.
- Drug-Induced Parkinsonism: Caused by medications that block dopamine receptors, most commonly antipsychotics and certain anti-nausea drugs. Symptoms typically resolve once the offending medication is discontinued or reduced.
- Vascular Parkinsonism: Results from small-vessel cerebrovascular disease affecting brain regions that control movement. Predominantly affects gait and lower body function, with tremor being less prominent.
- Atypical Parkinsonism (Parkinson-Plus Syndromes): Includes conditions such as Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), and Corticobasal Degeneration (CBD). These share some symptoms with Parkinson’s but progress differently, respond poorly to standard dopaminergic therapy and carry a different prognosis.
Distinguishing between these types is clinically essential because treatment approaches and disease trajectories differ significantly. This differentiation relies heavily on careful neurological examination and, in some cases, specialised imaging techniques.
How Is Parkinson’s Disease Diagnosed?
There is no single definitive test for Parkinson’s disease. Diagnosis is primarily clinical, based on medical history, symptom presentation and neurological examination by a specialist.
The typical diagnostic pathway includes:
- Neurological Examination: A neurologist evaluates coordination, muscle tone, gait, reflexes and the presence of characteristic motor signs such as tremor, rigidity and bradykinesia.
- Response to Medication: A trial of levodopa (the primary Parkinson’s medication) may be administered. Significant symptom improvement with levodopa strongly supports the diagnosis and helps differentiate idiopathic Parkinson’s from atypical Parkinsonism.
- Advanced Imaging: DaTscan, a specialised imaging technique, can visualise the dopamine transporter system in the brain. While not always required, it helps differentiate Parkinson’s from essential tremor and other movement disorders.
- Laboratory Tests: Blood tests are ordered to rule out conditions that can mimic Parkinson’s disease symptoms, including thyroid disorders, Wilson’s disease, vitamin B12 deficiency and liver or kidney dysfunction. These tests form a crucial part of the differential diagnosis process.
At Unipath Specialty Laboratory in Ahmedabad, comprehensive blood panels and metabolic screening are available to support the differential diagnostic workup. For cases where a genetic basis is suspected, particularly in early-onset Parkinson’s or familial clusters, whole exome sequencing can identify causative mutations that inform both prognosis and family screening. Accurate laboratory results help neurologists rule out reversible causes of Parkinsonism and refine the diagnosis with confidence.
Parkinson’s Treatment: What Options Are Available?
While there is no cure for Parkinson’s disease, a range of evidence-based Parkinson’s treatment options can significantly improve symptom management and quality of life, particularly when initiated early.
Medication
- Levodopa-Carbidopa: The most effective pharmacological treatment. Levodopa is converted to dopamine in the brain; carbidopa prevents its premature breakdown outside the brain, reducing side effects such as nausea.
- Dopamine Agonists: Medications that mimic dopamine’s effects. Often used in younger patients or in combination with levodopa to manage motor fluctuations.
- MAO-B Inhibitors and COMT Inhibitors: Extend the duration of levodopa’s effect by slowing dopamine breakdown in the brain.
- Amantadine: May be prescribed to manage involuntary movements (dyskinesia) that can develop with long-term levodopa use.
Surgical Intervention
- Deep Brain Stimulation (DBS): For patients whose symptoms are no longer adequately controlled by medication, DBS involves implanting electrodes into specific brain regions (typically the subthalamic nucleus or globus pallidus). These electrodes deliver controlled electrical impulses that regulate abnormal neural activity, reducing tremor, rigidity and dyskinesia.
Rehabilitation Therapies
- Physiotherapy: Targeted exercise programs improve flexibility, balance, gait, and overall mobility. High-intensity exercise has shown promise in slowing functional decline.
- Speech-Language Therapy: Addresses speech volume, articulation, and swallowing difficulties that commonly develop as the disease progresses.
- Occupational Therapy: Helps patients adapt daily activities and home environments to maintain independence for as long as possible.
Lifestyle and Supportive Measures
- Regular cardiovascular exercise (walking, swimming, cycling) is consistently associated with better motor outcomes and improved mood.
- A balanced diet with adequate fibre and hydration helps manage constipation, one of the most common non-motor symptoms.
- Sleep hygiene practices and, where necessary, medical management of sleep disorders improve overall functioning and quality of life.
- Regular testing and monitoring are recommended when medication is prescribed, particularly to track liver function, kidney function and other relevant metabolic parameters over time.
When to Seek Medical Evaluation?
Early evaluation makes a measurable difference in long-term outcomes. A consultation with a neurologist or movement disorder specialist is warranted if any of the following patterns are observed:
- A new or persistent tremor in a hand, finger, foot, or jaw, particularly at rest
- Noticeable stiffness or slowness of movement that was not present previously
- Changes in handwriting size (micrographia)
- Reduced facial expression or a “masked” appearance noted by family members
- Shuffling gait, difficulty initiating movement or frequent unexplained falls
- Persistent loss of smell, combined with any of the above
A neurological evaluation does not presuppose a diagnosis. It provides clarity as clarity is the foundation of every effective treatment plan.
Unipath Specialty Laboratory supports this diagnostic process by providing accurate, NABL-accredited blood tests, metabolic panels and specialised screening that help neurologists differentiate Parkinson’s disease from conditions with overlapping symptoms.
Unipath Diagnostic Services: Serviceable Cities
Ahmedabad • Surat • Baroda • Kolkata • Jaipur • Mumbai • Siliguri • Jamnagar
For test bookings and inquiries: unipath.in
Disclaimer
Unipath does not represent or warrant that the content or information provided through our blog is accurate, complete, or current, nor that our blog content will be uninterrupted or error-free. We do not guarantee that any defects in our blog content will be corrected or that our server or the server hosting it is free of viruses or other harmful components. Unipath makes no warranties or representations regarding the use of materials in our blog content concerning their correctness, accuracy, adequacy, usefulness, timeliness, reliability, or otherwise, to the fullest extent permitted by applicable law. Information available via our Platform and blog content may reference products, programs, or services not available in your region. You understand and acknowledge that your sole and exclusive remedy for any defect in or dissatisfaction with our blog content is to cease using it.
References & Citations
Mayo Clinic – Parkinson’s Disease: Symptoms and Causes
Mayo Clinic – Parkinson’s Disease: Diagnosis and Treatment
NINDS – Parkinson’s Disease
National Institute on Ageing – Parkinson’s Disease: Causes, Symptoms, and Treatments
World Health Organisation – Parkinson's Disease